K. Kinzler and B. Vogelstein, Cancer-susceptibility genes. Gatekeepers and caretakers, Nature, vol.386, issue.6627, 1997.

D. Hanahan and R. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011.
DOI : 10.1016/j.cell.2011.02.013

I. Garkavtsev, A. Kazarov, A. Gudkov, and K. Riabowol, Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation, Nature Genetics, vol.92, issue.4, pp.415-42010, 1996.
DOI : 10.1016/0092-8674(89)90914-8

M. Nagashima, M. Shiseki, K. Miura, K. Hagiwara, S. Linke et al., DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53, Proceedings of the National Academy of Sciences, vol.98, issue.17, pp.9671-9676, 2001.
DOI : 10.1073/pnas.161151798

M. Nagashima, M. Shiseki, R. Pedeux, S. Okamura, M. Kitahama-shiseki et al., A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis, Oncogene, vol.22, issue.3, pp.343-350, 2003.
DOI : 10.1038/sj.onc.1206115

Y. Shimada, A. Saito, M. Suzuki, E. Takahashi, and M. Horie, Cloning of a novel gene (ING1L) homologous to ING1, a candidate tumor suppressor, Cytogenetic and Genome Research, vol.83, issue.3-4, pp.3-4232, 1998.
DOI : 10.1159/000015188

R. Loewith, M. Meijer, S. Lees-miller, K. Riabowol, and D. Young, Three Yeast Proteins Related to the Human Candidate Tumor Suppressor p33ING1 Are Associated with Histone Acetyltransferase Activities, Molecular and Cellular Biology, vol.20, issue.11, pp.3807-3816, 2000.
DOI : 10.1128/MCB.20.11.3807-3816.2000

G. He, C. Helbing, M. Wagner, C. Sensen, and K. Riabowol, Phylogenetic Analysis of the ING Family of PHD Finger Proteins, Molecular Biology and Evolution, vol.22, issue.1, 2005.
DOI : 10.1093/molbev/msh256

M. Soliman and K. Riabowol, After a decade of study-ING, a PHD for a versatile family of proteins, Trends in Biochemical Sciences, vol.32, issue.11, pp.509-519, 2007.
DOI : 10.1016/j.tibs.2007.08.006

W. Lee, D. Lee, W. Chung, and C. Kwon, Arabidopsis ING and Alfin1-like protein families localize to the nucleus and bind to H3K4me3/2 via plant homeodomain fingers. The Plant journal : for cell and molecular biology, pp.511-524, 2009.

M. Wagner, M. Gogela-spehar, R. Skirrow, R. Johnston, K. Riabowol et al., Expression of Novel ING Variants Is Regulated by Thyroid Hormone in the Xenopus laevis Tadpole, Journal of Biological Chemistry, vol.276, issue.50, pp.47013-47020, 2001.
DOI : 10.1074/jbc.M106965200

D. Ythier, D. Larrieu, C. Brambilla, E. Brambilla, and R. Pedeux, The new tumor suppressor genes ING: Genomic structure and status in cancer, International Journal of Cancer, vol.356, issue.7, pp.1483-1490, 2008.
DOI : 10.1002/ijc.23790
URL : https://hal.archives-ouvertes.fr/inserm-00326536

J. Kichina, M. Zeremski, L. Aris, K. Gurova, E. Walker et al., Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas, Oncogene, vol.23, issue.6, pp.857-866, 2006.
DOI : 10.1074/jbc.274.45.32172

A. Coles, H. Liang, Z. Zhu, C. Marfella, J. Kang et al., Deletion of p37Ing1 in Mice Reveals a p53-Independent Role for Ing1 in the Suppression of Cell Proliferation, Apoptosis, and Tumorigenesis, Cancer Research, vol.67, issue.5, pp.2054-2061100008, 1158.
DOI : 10.1158/0008-5472.CAN-06-3558

A. Coles, C. Marfella, A. Imbalzano, H. Steinman, D. Garlick et al., p37Ing1b Regulates B-Cell Proliferation and Cooperates with p53 to Suppress Diffuse Large B-Cell Lymphomagenesis, Cancer Research, vol.68, issue.21, pp.8705-8714, 2008.
DOI : 10.1158/0008-5472.CAN-08-0923

M. Saito, K. Kumamoto, A. Robles, I. Horikawa, B. Furusato et al., Targeted Disruption of Ing2 Results in Defective Spermatogenesis and Development of Soft-Tissue Sarcomas, PLoS ONE, vol.125, issue.11, 2010.
DOI : 10.1371/journal.pone.0015541.s013

M. Zeremski, J. Hill, S. Kwek, I. Grigorian, K. Gurova et al., Structure and Regulation of the Mouse ing1 Gene: THREE ALTERNATIVE TRANSCRIPTS ENCODE TWO PHD FINGER PROTEINS THAT HAVE OPPOSITE EFFECTS ON p53 FUNCTION, Journal of Biological Chemistry, vol.274, issue.45, pp.32172-32181, 1999.
DOI : 10.1074/jbc.274.45.32172

A. Walzak, N. Veldhoen, X. Feng, K. Riabowol, and C. Helbing, Expression profiles of mRNA transcript variants encoding the human inhibitor of growth tumor suppressor gene family in normal and neoplastic tissues, Experimental Cell Research, vol.314, issue.2, pp.273-285, 2008.
DOI : 10.1016/j.yexcr.2007.07.029

K. Cheung, J. Bush, J. Jia, W. Li, and G. , Expression of the novel tumour suppressor p33(ING1)is independent of p53, British Journal of Cancer, vol.83, issue.11, pp.1468-1472, 2000.
DOI : 10.1054/bjoc.2000.1464

M. Unoki, K. Kumamoto, A. Robles, J. Shen, Z. Zheng et al., A novel ING2 isoform, ING2b, synergizes with ING2a to prevent cell cycle arrest and apoptosis, FEBS Letters, vol.29, issue.28, pp.3868-3874, 2008.
DOI : 10.1016/j.febslet.2008.10.024

K. Kumamoto, E. Spillare, K. Fujita, I. Horikawa, T. Yamashita et al., Nutlin-3a Activates p53 to Both Down-regulate Inhibitor of Growth 2 and Up-regulate mir-34a, mir-34b, and mir-34c Expression, and Induce Senescence, Cancer Research, vol.68, issue.9, pp.3193-3203100008, 1158.
DOI : 10.1158/0008-5472.CAN-07-2780

K. Kumamoto, K. Fujita, R. Kurotani, M. Saito, M. Unoki et al., ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression, International Journal of Cancer, vol.37, issue.6, pp.1306-1315, 2009.
DOI : 10.1002/ijc.24437

S. Eapen, S. Netherton, K. Sarker, L. Deng, A. Chan et al., Identification of a Novel Function for the Chromatin Remodeling Protein ING2 in Muscle Differentiation, PLoS ONE, vol.5, issue.7, 2012.
DOI : 10.1371/journal.pone.0040684.s003

O. Gozani, P. Karuman, D. Jones, D. Ivanov, J. Cha et al., The PHD Finger of the Chromatin-Associated Protein ING2 Functions as a Nuclear Phosphoinositide Receptor, Cell, vol.114, issue.1, pp.99-111, 2003.
DOI : 10.1016/S0092-8674(03)00480-X

P. Pena, F. Davrazou, X. Shi, K. Walter, V. Verkhusha et al., Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2, Nature, vol.442, issue.7098, pp.100-103, 2006.

X. Shi, T. Hong, K. Walter, M. Ewalt, E. Michishita et al., ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression, Nature, vol.124, issue.7098, pp.96-99, 1038.
DOI : 10.1038/nature04835

A. Kuzmichev, Y. Zhang, H. Erdjument-bromage, P. Tempst, and D. Reinberg, Role of the Sin3-Histone Deacetylase Complex in Growth Regulation by the Candidate Tumor Suppressor p33ING1, Molecular and Cellular Biology, vol.22, issue.3, pp.835-848, 2002.
DOI : 10.1128/MCB.22.3.835-848.2002

P. Pena, R. Hom, T. Hung, H. Lin, A. Kuo et al., Histone H3K4me3 Binding Is Required for the DNA Repair and Apoptotic Activities of ING1 Tumor Suppressor, Journal of Molecular Biology, vol.380, issue.2, pp.303-312, 2008.
DOI : 10.1016/j.jmb.2008.04.061

D. Skowyra, M. Zeremski, N. Neznanov, M. Li, Y. Choi et al., Differential Association of Products of Alternative Transcripts of the Candidate Tumor Suppressor ING1 with the mSin3/HDAC1 Transcriptional Corepressor Complex, Journal of Biological Chemistry, vol.276, issue.12, pp.8734-8739, 2001.
DOI : 10.1074/jbc.M007664200

M. Yaffe, K. Rittinger, S. Volinia, P. Caron, A. Aitken et al., The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity, Cell, vol.91, issue.7, pp.961-971, 1997.
DOI : 10.1016/S0092-8674(00)80487-0

W. Gong, M. Russell, K. Suzuki, and K. Riabowol, Subcellular Targeting of p33ING1b by Phosphorylation-Dependent 14-3-3 Binding Regulates p21WAF1 Expression, Molecular and Cellular Biology, vol.26, issue.8, pp.2947-2954, 2006.
DOI : 10.1128/MCB.26.8.2947-2954.2006

M. Russell, M. Soliman, D. Schriemer, and K. Riabowol, ING1 protein targeting to the nucleus by karyopherins is necessary for activation of p21, Biochemical and Biophysical Research Communications, vol.374, issue.3, pp.490-495, 2008.
DOI : 10.1016/j.bbrc.2008.07.076

M. Scott, P. Bonnefin, D. Vieyra, F. Boisvert, D. Young et al., UVinduced binding of ING1 to PCNA regulates the induction of apoptosis, Journal of cell science, vol.114, pp.3455-3462, 2001.

X. Han, X. Feng, J. Rattner, H. Smith, P. Bose et al., Tethering by lamin A stabilizes and targets the ING1 tumour suppressor, Nature Cell Biology, vol.314, issue.11, pp.1333-1340, 1038.
DOI : 10.1038/ncb1792

X. Feng, Y. Hara, and K. Riabowol, Different HATS of the ING1 gene family, Trends in Cell Biology, vol.12, issue.11, pp.532-538, 2002.
DOI : 10.1016/S0962-8924(02)02391-7

A. Coles and S. Jones, The ING gene family in the regulation of cell growth and tumorigenesis, Journal of Cellular Physiology, vol.78, issue.1, pp.45-57, 2009.
DOI : 10.1002/jcp.21583

S. Culurgioni, I. Munoz, A. Moreno, A. Palacios, M. Villate et al., Crystal Structure of Inhibitor of Growth 4 (ING4) Dimerization Domain Reveals Functional Organization of ING Family of Chromatin-binding Proteins, Journal of Biological Chemistry, vol.287, issue.14, 2012.
DOI : 10.1074/jbc.M111.330001

A. Palacios, A. Moreno, B. Oliveira, T. Rivera, J. Prieto et al., The Dimeric Structure and the Bivalent Recognition of H3K4me3 by the Tumor Suppressor ING4 Suggests a Mechanism for Enhanced Targeting of the HBO1 Complex to Chromatin, Journal of Molecular Biology, vol.396, issue.4, pp.1117-1127, 2010.
DOI : 10.1016/j.jmb.2009.12.049

M. Garate, E. Campos, J. Bush, H. Xiao, and G. Li, Phosphorylation of the tumor suppressor p33ING1b at Ser-126 influences its protein stability and proliferation of melanoma cells, The FASEB Journal, vol.21, issue.13, pp.3705-371607, 2007.
DOI : 10.1096/fj.07-8069com

M. Garate, R. Wong, E. Campos, Y. Wang, and G. Li, NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33ING1b, EMBO reports, vol.63, issue.6, pp.576-58148, 2008.
DOI : 10.1016/j.molcel.2005.07.019

J. Nie, L. Liu, M. Wu, G. Xing, S. He et al., HECT ubiquitin ligase Smurf1 targets the tumor suppressor ING2 for ubiquitination and degradation, FEBS Letters, vol.314, issue.14, pp.3005-3012, 2010.
DOI : 10.1016/j.febslet.2010.05.033

C. Chen and L. Matesic, The Nedd4-like family of E3 ubiquitin ligases and cancer, Cancer and Metastasis Reviews, vol.11, issue.10, pp.587-604, 2007.
DOI : 10.1007/s10555-007-9091-x

K. Kwei, A. Shain, R. Bair, K. Montgomery, C. Karikari et al., SMURF1 Amplification Promotes Invasiveness in Pancreatic Cancer, PLoS ONE, vol.406, issue.8, 2011.
DOI : 10.1371/journal.pone.0023924.s002

D. Ythier, E. Brambilla, R. Binet, D. Nissou, A. Vesin et al., Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma, Lung Cancer, vol.69, issue.2, pp.180-186, 2010.
DOI : 10.1016/j.lungcan.2009.11.006

M. Gunduz, E. Gunduz, R. Rivera, and H. Nagatsuka, The Inhibitor of Growth (ING) Gene Family: Potential Role in Cancer Therapy, Current Cancer Drug Targets, vol.8, issue.4, pp.275-284, 2008.
DOI : 10.2174/156800908784533454

L. Chen, N. Matsubara, T. Yoshino, T. Nagasaka, N. Hoshizima et al., Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer, Cancer Res, issue.11, pp.614345-4349, 2001.

E. Tokunaga, Y. Maehara, E. Oki, K. Kitamura, Y. Kakeji et al., Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers, Cancer Letters, vol.152, issue.1, pp.15-22, 2000.
DOI : 10.1016/S0304-3835(99)00434-6

T. Toyama, H. Iwase, P. Watson, H. Muzik, E. Saettler et al., Suppression of ING1 expression in sporadic breast cancer, Oncogene, vol.18, issue.37, pp.5187-5193, 1999.
DOI : 10.1038/sj.onc.1202905

B. Chen, E. Campos, R. Crawford, M. Martinka, and G. Li, Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma, International Journal of Oncology, vol.22, issue.4, pp.927-931, 2003.
DOI : 10.3892/ijo.22.4.927

G. Nouman, J. Anderson, S. Crosier, J. Shrimankar, J. Lunec et al., Downregulation of nuclear expression of the p33ING1b inhibitor of growth protein in invasive carcinoma of the breast, Journal of Clinical Pathology, vol.56, issue.7, pp.507-511, 2003.
DOI : 10.1136/jcp.56.7.507

M. Takahashi, T. Ozaki, S. Todo, and A. Nakagawara, Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas, Oncology Reports, vol.12, issue.4, pp.811-816, 2004.
DOI : 10.3892/or.12.4.811

H. Zhang, K. Pan, H. Wang, D. Weng, H. Song et al., Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma, Cancer Letters, vol.261, issue.2, pp.183-192, 2008.
DOI : 10.1016/j.canlet.2007.11.019

S. Borkosky, M. Gunduz, H. Nagatsuka, L. Beder, E. Gunduz et al., Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma, Journal of Cancer Research and Clinical Oncology, vol.261, issue.2, pp.703-713, 2009.
DOI : 10.1007/s00432-008-0507-y

E. Sironi, A. Cerri, D. Tomasini, S. Sirchia, G. Porta et al., Loss of heterozygosity on chromosome 4q32-35 in sporadic basal cell carcinomas: evidence for the involvement of p33ING2/ING1L and SAP30 genes, Journal of Cutaneous Pathology, vol.22, issue.4, pp.318-322187, 2004.
DOI : 10.1016/S0168-9525(00)02060-6

H. Zhang, H. Ma, Q. Wang, M. Chen, D. Weng et al., Analysis of loss of heterozygosity on chromosome 4q in hepatocellular carcinoma using high-throughput SNP array, Oncol Rep, vol.23, issue.2, pp.445-455, 2010.

T. Okano, A. Gemma, Y. Hosoya, Y. Hosomi, M. Nara et al., Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer, Oncology Reports, vol.15, issue.3, pp.545-549, 2006.
DOI : 10.3892/or.15.3.545

F. Lu, D. Dai, M. Martinka, V. Ho, and G. Li, Nuclear ING2 expression is reduced in human cutaneous melanomas, British Journal of Cancer, vol.128, issue.1, pp.80-866603205, 2006.
DOI : 10.1158/0008-5472.CAN-05-3444

D. Vieyra, D. Senger, T. Toyama, H. Muzik, P. Brasher et al., Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors. Clinical cancer research : an official journal of the, American Association for Cancer Research, vol.916, issue.1, pp.5952-5961, 2003.

D. Engelmann and B. Putzer, The Dark Side of E2F1: In Transit beyond Apoptosis, Cancer Research, vol.72, issue.3, pp.571-575, 2012.
DOI : 10.1158/0008-5472.CAN-11-2575

X. Guo, C. Jing, L. Li, L. Zhang, Y. Shi et al., Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene, World journal of gastroenterology : WJG, vol.17, issue.14, pp.1895-1902, 2011.

A. Bannister and T. Kouzarides, Histone Methylation: Recognizing the Methyl Mark, Methods Enzymol, vol.376, issue.03, pp.269-28810, 2004.
DOI : 10.1016/S0076-6879(03)76018-2

M. Abad, A. Moreno, A. Palacios, M. Narita, F. Blanco et al., The tumor suppressor ING1 contributes to epigenetic control of cellular senescence, Aging Cell, vol.123, issue.1, 2011.
DOI : 10.1111/j.1474-9726.2010.00651.x

D. Vieyra, R. Loewith, M. Scott, P. Bonnefin, F. Boisvert et al., Human ING1 Proteins Differentially Regulate Histone Acetylation, Journal of Biological Chemistry, vol.277, issue.33, pp.29832-29839, 2002.
DOI : 10.1074/jbc.M200197200

D. Gomez-cabello, S. Callejas, A. Benguria, A. Moreno, J. Alonso et al., Regulation of the MicroRNA Processor DGCR8 by the Tumor Suppressor ING1, Cancer Research, vol.70, issue.5, pp.1866-1874, 2010.
DOI : 10.1158/0008-5472.CAN-09-2088

X. Shi, C. Tepper, and R. Devere-white, Cancerous miRNAs and their regulation, Cell Cycle, vol.7, issue.11, pp.1529-1538, 2008.
DOI : 10.4161/cc.7.11.5977

M. Takahashi, N. Seki, T. Ozaki, M. Kato, T. Kuno et al., Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG, Cancer Res, vol.62, issue.8, pp.2203-2209, 2002.

N. Li, Q. Li, X. Cao, G. Zhao, L. Xue et al., expression and induces cellular senescence, FEBS Letters, vol.121, issue.19, pp.3106-3112, 2011.
DOI : 10.1016/j.febslet.2011.08.044

H. Kataoka, P. Bonnefin, D. Vieyra, X. Feng, Y. Hara et al., ING1 represses transcription by direct DNA binding and through effects on p53, Cancer Res, vol.63, issue.18, pp.5785-5792, 2003.

H. Shimada, T. Liu, T. Ochiai, T. Shimizu, Y. Haupt et al., Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33ING1 in T.Tn human esophageal carcinoma cells, Oncogene, vol.21, issue.8, pp.1208-1216, 2002.
DOI : 10.1038/sj.onc.1205176

I. Garkavtsev, I. Grigorian, V. Ossovskaya, M. Chernov, P. Chumakov et al., The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control, Nature, vol.391, issue.6664, pp.295-2981034675, 1038.

C. Helbing, C. Veillette, K. Riabowol, R. Johnston, and I. Garkavtsev, A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis, Cancer Res, vol.57, issue.7, pp.1255-1258, 1997.

M. Soliman, P. Berardi, S. Pastyryeva, P. Bonnefin, X. Feng et al., ING1a expression increases during replicative senescence and induces a senescent phenotype, Aging Cell, vol.12, issue.6, pp.783-794, 2008.
DOI : 10.1111/j.1474-9726.2008.00427.x

D. Vieyra, T. Toyama, Y. Hara, D. Boland, R. Johnston et al., ING1 isoforms differentially affect apoptosis in a cell age-dependent manner, Cancer Res, vol.62, issue.15, pp.4445-4452, 2002.

M. Abad, C. Menendez, A. Fuchtbauer, M. Serrano, E. Fuchtbauer et al., Ing1 Mediates p53 Accumulation and Chromatin Modification in Response to Oncogenic Stress, Journal of Biological Chemistry, vol.282, issue.42, pp.31060-31067, 2007.
DOI : 10.1074/jbc.M701639200

F. Tsang, L. Po, K. Leung, A. Lau, W. Siu et al., ING1b decreases cell proliferation through p53-dependent and -independent mechanisms, FEBS Letters, vol.21, issue.3, pp.277-285, 2003.
DOI : 10.1016/S0014-5793(03)01024-X

K. Leung, L. Po, F. Tsang, W. Siu, A. Lau et al., The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2, Cancer Res, vol.62, issue.17, pp.4890-4893, 2002.

J. Zawacka-pankau, A. Kostecka, A. Sznarkowska, E. Hedstrom, and A. Kawiak, p73 tumor suppressor protein: A close relative of p53 not only in structure but also in anti-cancer approach?, Cell Cycle, vol.9, issue.4, pp.720-728, 2010.
DOI : 10.4161/cc.9.4.10668

G. Melino, p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53, Cell Death and Differentiation, vol.60, issue.9, pp.1487-1499, 2011.
DOI : 10.1038/onc.2010.215

N. Allocati, D. Ilio, C. , and D. Laurenzi, p63/p73 in the control of cell cycle and cell death, Experimental Cell Research, vol.318, issue.11, 2012.
DOI : 10.1016/j.yexcr.2012.01.023

O. Binda, C. Nassif, and P. Branton, SIRT1 negatively regulates HDAC1-dependent transcriptional repression by the RBP1 family of proteins, Oncogene, vol.983, issue.24, pp.3384-3392, 2008.
DOI : 10.1016/S1097-2765(00)80102-1

S. Shieh, M. Ikeda, Y. Taya, and C. Prives, DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2, Cell, vol.91, issue.3, pp.325-334, 1997.
DOI : 10.1016/S0092-8674(00)80416-X

S. Thalappilly, X. Feng, S. Pastyryeva, K. Suzuki, D. Muruve et al., The p53 Tumor Suppressor Is Stabilized by Inhibitor of Growth 1 (ING1) by Blocking Polyubiquitination, PLoS ONE, vol.277, issue.6, 2011.
DOI : 10.1371/journal.pone.0021065.s009

L. Gonzalez, J. Freije, C. S. Lopez-otin, C. Serrano, M. Palmero et al., A functional link between the tumour suppressors ARF and p33ING1, Oncogene, vol.274, issue.37, pp.5173-5179, 2006.
DOI : 10.1038/sj.onc.1209526

U. Tallen, M. Truss, F. Kunitz, S. Wellmann, B. Unryn et al., Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death, Journal of Neuro-Oncology, vol.6, issue.1, pp.23-30, 2008.
DOI : 10.1007/s11060-007-9436-x

X. Feng, S. Bonni, and K. Riabowol, HSP70 Induction by ING Proteins Sensitizes Cells to Tumor Necrosis Factor Alpha Receptor-Mediated Apoptosis, Molecular and Cellular Biology, vol.26, issue.24, pp.9244-92551001538, 1128.
DOI : 10.1128/MCB.01538-06

Y. Shi, Z. Tu, D. Tang, H. Zhang, M. Liu et al., THE INHIBITION OF LPS-INDUCED PRODUCTION OF INFLAMMATORY CYTOKINES BY HSP70 INVOLVES INACTIVATION OF THE NF-??B PATHWAY BUT NOT THE MAPK PATHWAYS, Shock, vol.26, issue.3, pp.277-284, 2006.
DOI : 10.1097/01.shk.0000223134.17877.ad

R. Ran, A. Lu, L. Zhang, Y. Tang, H. Zhu et al., Hsp70 promotes TNF-mediated apoptosis by binding IKK?? and impairing NF-??B survival signaling, Genes & Development, vol.18, issue.12, pp.1466-1481, 2004.
DOI : 10.1101/gad.1188204
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC423196

L. Ma, N. Chang, S. Guo, Q. Li, Z. Zhang et al., CSIG Inhibits PTEN Translation in Replicative Senescence, Molecular and Cellular Biology, vol.28, issue.20, pp.6290-63011000142, 1128.
DOI : 10.1128/MCB.00142-08

N. Li, G. Zhao, T. Chen, L. Xue, L. Ma et al., Nucleolar protein CSIG is required for p33ING1 function in UV-induced apoptosis, Cell Death and Disease, vol.313, issue.3, 2012.
DOI : 10.1038/cddis.2012.22

K. Cheung, J. Mitchell, D. Lin, P. Li, and G. , The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA, Cancer Res, issue.13, pp.614974-4977, 2001.

C. Niehrs and A. Schafer, Active DNA demethylation by Gadd45 and DNA repair, Trends in Cell Biology, vol.22, issue.4, pp.220-227, 2012.
DOI : 10.1016/j.tcb.2012.01.002

E. Campos, M. Martinka, D. Mitchell, D. Dai, and G. Li, Mutations of the ING1 tumor suppressor gene detected in human melanoma abrogate nucleotide excision repair, International Journal of Oncology, vol.25, issue.1, pp.73-80, 2004.
DOI : 10.3892/ijo.25.1.73

W. Kuo, Y. Wang, R. Wong, E. Campos, and G. Li, The ING1b tumor suppressor facilitates nucleotide excision repair by promoting chromatin accessibility to XPA, Experimental Cell Research, vol.313, issue.8, pp.1628-1638, 2007.
DOI : 10.1016/j.yexcr.2007.02.010

R. Wong, H. Lin, S. Khosravi, B. Piche, S. Jafarnejad et al., Tumour suppressor ING1b maintains genomic stability upon replication stress, Nucleic Acids Research, vol.39, issue.9, pp.3632-3642, 2011.
DOI : 10.1093/nar/gkq1337
URL : http://doi.org/10.1093/nar/gkq1337

K. Watanabe, S. Tateishi, M. Kawasuji, T. Tsurimoto, H. Inoue et al., Rad18 guides pol?? to replication stalling sites through physical interaction and PCNA monoubiquitination, The EMBO Journal, vol.7, issue.19, pp.3886-3896, 2004.
DOI : 10.1093/emboj/cdf534
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC522788

C. Hoege, B. Pfander, G. Moldovan, G. Pyrowolakis, and S. Jentsch, RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO, Nature, vol.78, issue.6903, pp.135-14110, 1038.
DOI : 10.1074/jbc.275.18.13321

P. Yu, B. Huang, M. Shen, C. Lau, E. Chan et al., (PAF), a novel PCNA associated factor with increased expression in tumor tissues, Oncogene, vol.20, issue.4, pp.15484-489, 2001.

T. Krishna, X. Kong, S. Gary, P. Burgers, and J. Kuriyan, Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA, Cell, vol.79, issue.7, pp.1233-1243, 1994.
DOI : 10.1016/0092-8674(94)90014-0

J. Gulbis, Z. Kelman, J. Hurwitz, O. Donnell, M. Kuriyan et al., Structure of the C-Terminal Region of p21WAF1/CIP1 Complexed with Human PCNA, Cell, vol.87, issue.2, pp.297-306, 1996.
DOI : 10.1016/S0092-8674(00)81347-1

F. Simpson, L. Van-bueren, K. Butterfield, N. Bennetts, J. Bowles et al., The PCNA-associated factor KIAA0101/p15 binds the potential tumor suppressor product p33ING1b, Experimental Cell Research, vol.312, issue.1, pp.73-85, 2006.
DOI : 10.1016/j.yexcr.2005.09.020

P. Pena, C. Musselman, A. Kuo, O. Gozani, and T. Kutateladze, NMR assignments and histone specificity of the ING2 PHD finger, Magnetic Resonance in Chemistry, vol.104, issue.4, pp.352-358, 2009.
DOI : 10.1002/mrc.2390

K. Smith, S. Martin-brown, L. Florens, M. Washburn, and J. Workman, Deacetylase Inhibitors Dissociate the Histone-Targeting ING2 Subunit from the Sin3 Complex, Chemistry & Biology, vol.17, issue.1, pp.65-74, 2010.
DOI : 10.1016/j.chembiol.2009.12.010

Y. Doyon, C. Cayrou, M. Ullah, A. Landry, V. Cote et al., ING Tumor Suppressor Proteins Are Critical Regulators of Chromatin Acetylation Required for Genome Expression and Perpetuation, Molecular Cell, vol.21, issue.1, pp.51-64, 2006.
DOI : 10.1016/j.molcel.2005.12.007

R. Ryan and B. Bernstein, Molecular biology Genetic events that shape the cancer epigenome, Science, vol.336, issue.6088, 2012.

D. Ythier, D. Larrieu, R. Binet, O. Binda, C. Brambilla et al., Sumoylation of ING2 regulates the transcription mediated by Sin3A, Oncogene, vol.63, issue.44, 2010.
DOI : 10.1016/j.canlet.2007.11.019
URL : https://hal.archives-ouvertes.fr/hal-00744248

D. Larrieu, D. Ythier, C. Brambilla, and R. Pedeux, to S-phase transition by regulating p21 expression, Cell Cycle, vol.9, issue.19, pp.3984-399013208, 2010.
DOI : 10.4161/cc.9.19.13208
URL : https://hal.archives-ouvertes.fr/hal-00744254

M. Tian, J. Neil, and W. Schiemann, Transforming growth factor-?? and the hallmarks of cancer, Cellular Signalling, vol.23, issue.6, pp.951-962, 2011.
DOI : 10.1016/j.cellsig.2010.10.015

K. Sarker, H. Kataoka, A. Chan, S. Netherton, I. Pot et al., ING2 as a Novel Mediator of Transforming Growth Factor-??-dependent Responses in Epithelial Cells, Journal of Biological Chemistry, vol.283, issue.19, pp.13269-13279, 2008.
DOI : 10.1074/jbc.M708834200

R. Pedeux, S. Sengupta, J. Shen, O. Demidov, S. Saito et al., ING2 Regulates the Onset of Replicative Senescence by Induction of p300-Dependent p53 Acetylation, Molecular and Cellular Biology, vol.25, issue.15, pp.6639-66486639, 2005.
DOI : 10.1128/MCB.25.15.6639-6648.2005

M. Kaadige and D. Ayer, The Polybasic Region That Follows the Plant Homeodomain Zinc Finger 1 of Pf1 Is Necessary and Sufficient for Specific Phosphoinositide Binding, Journal of Biological Chemistry, vol.281, issue.39, 2006.
DOI : 10.1074/jbc.M605624200

D. Jones, Y. Bultsma, W. Keune, J. Halstead, D. Elouarrat et al., Nuclear PtdIns5P as a Transducer of Stress Signaling: An In Vivo Role for PIP4Kbeta, Molecular Cell, vol.23, issue.5, pp.685-695, 2006.
DOI : 10.1016/j.molcel.2006.07.014

O. Gozani, S. Field, C. Ferguson, M. Ewalt, C. Mahlke et al., Modification of protein sub-nuclear localization by synthetic phosphoinositides: evidence for nuclear phosphoinositide signaling mechanisms Advances in enzyme regulation, pp.171-185, 2005.

W. Huang, H. Zhang, F. Davrazou, T. Kutateladze, X. Shi et al., Stabilized Phosphatidylinositol-5-Phosphate Analogues as Ligands for the Nuclear Protein ING2:?? Chemistry, Biology, and Molecular Modeling, Journal of the American Chemical Society, vol.129, issue.20, pp.6498-650610, 1021.
DOI : 10.1021/ja070195b

A. Costanzo, P. Merlo, N. Pediconi, M. Fulco, V. Sartorelli et al., DNA Damage-Dependent Acetylation of p73 Dictates the Selective Activation of Apoptotic Target Genes, Molecular Cell, vol.9, issue.1, pp.175-186, 2002.
DOI : 10.1016/S1097-2765(02)00431-8

X. Zeng, H. Lee, Q. Zhang, and H. Lu, p300 Does Not Require Its Acetylase Activity to Stimulate p73 Function, Journal of Biological Chemistry, vol.276, issue.1, pp.48-52, 2001.
DOI : 10.1074/jbc.C000722200

J. Chen, F. Ghazawi, and Q. Li, Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes, Epigenetics, vol.25, issue.6, pp.509-515, 2010.
DOI : 10.4161/epi.2.2.4326

E. Kalkhoven, CBP and p300: HATs for different occasions, Biochemical Pharmacology, vol.68, issue.6, pp.1145-1155, 2004.
DOI : 10.1016/j.bcp.2004.03.045

D. Larrieu, D. Ythier, R. Binet, C. Brambilla, E. Brambilla et al., ING2 controls the progression of DNA replication forks to maintain genome stability, EMBO reports, vol.114, issue.10, pp.1168-1174, 2009.
DOI : 10.1002/ijc.23790

S. Hasan, P. Hassa, R. Imhof, and M. Hottiger, Transcription coactivator p300 binds PCNA and may have a role in DNA repair synthesis, Nature, vol.410, issue.6826, pp.387-3911035066610, 1038.
DOI : 10.1038/35066610

D. Larrieu and R. Pedeux, SharING out the roles in replicatING DNA, Cell Cycle, vol.8, issue.22, pp.3623-36249947, 2009.
DOI : 10.4161/cc.8.22.9947
URL : https://hal.archives-ouvertes.fr/inserm-00869422

J. Wang, M. Chin, and G. Li, The Novel Tumor Suppressor p33ING2 Enhances Nucleotide Excision Repair via Inducement of Histone H4 Acetylation and Chromatin Relaxation, Cancer Research, vol.66, issue.4, pp.1906-1911, 1906.
DOI : 10.1158/0008-5472.CAN-05-3444

Y. Wang, J. Wang, and G. Li, Leucine zipper-like domain is required for tumor suppressor ING2-mediated nucleotide excision repair and apoptosis, FEBS Letters, vol.21, issue.16, pp.3787-3793, 2006.
DOI : 10.1016/j.febslet.2006.05.065

M. Kim, J. Shin, H. Eun, and J. Chung, The role of p300 histone acetyltransferase in UVinduced histone modifications and MMP-1 gene transcription, PLoS One, vol.4, issue.3, 2009.

R. Loewith, J. Smith, M. Meijer, T. Williams, N. Bachman et al., Pho23 Is Associated with the Rpd3 Histone Deacetylase and Is Required for Its Normal Function in Regulation of Gene Expression and Silencing in Saccharomyces cerevisiae, Journal of Biological Chemistry, vol.276, issue.26, pp.24068-24074, 2001.
DOI : 10.1074/jbc.M102176200

I. Garkavtsev and K. Riabowol, Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor., Molecular and Cellular Biology, vol.17, issue.4, pp.2014-2019, 1997.
DOI : 10.1128/MCB.17.4.2014

G. Sun, J. S. Baskaran, and R. , MMR/c-Abl-dependent activation of ING2/p73?? signaling regulates the cell death response to N-methyl-N???-nitro-N-nitrosoguanidine, Experimental Cell Research, vol.315, issue.18, pp.3163-3175, 2009.
DOI : 10.1016/j.yexcr.2009.09.010

D. Biasio, A. Campos-olivas, R. Sanchez, R. Lopez-alonso, J. Pantoja-uceda et al., Proliferating Cell Nuclear Antigen (PCNA) Interactions in Solution Studied by NMR, PLoS ONE, vol.287, issue.11, 2012.
DOI : 10.1371/journal.pone.0048390.s008

M. Stratton, P. Campbell, and P. Futreal, The cancer genome, Nature, vol.12, issue.7239, pp.719-724, 2009.
DOI : 10.1038/nature07943